A 3D-QSAR of pyridinone binding at the non-nucleoside binding site of HIV-1 reverse transcriptase: A hydropathic molecular dynamics approach.

被引：0
|
作者：
McGrath, CF
Tawa, GJ
Luke, BT
Kellogg, GE
Zaharevitz, DW
Pattabiraman, N
Gussio, R
机构：
[1] VCU, MCV, Richmond, VA 23284 USA
[2] NCI, AVP, SAIC, FBSC, Frederick, MD 21702 USA
[3] NCI, TSBDDG, ITB, DTP, Frederick, MD 21702 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 216卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
085-COMP
引用
收藏
页码：U708 / U708
页数：1
相关论文
共 50 条
  • [31] Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1
    Moreno, S
    Casado, JL
    Pérez-Elias, MI
    Dronda, F
    Antela, A
    Moreno, A
    Gutiérrez, C
    AIDS, 2003, 17 (09) : 1413 - 1414
  • [32] Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: A combinatorial approach
    V. T. Valuev-Elliston
    S. N. Kochetkov
    Biochemistry (Moscow), 2017, 82 : 1716 - 1743
  • [33] Mechanisms of resistance of HIV-1 reverse transcriptase to nucleoside and non-nucleoside inhibitors
    Boyer, PL
    Tantillo, C
    Ding, J
    Ferris, AL
    Clark, P
    Arnold, E
    Hughes, SH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 6 - 6
  • [34] Linear-response study on the binding affinity of non-nucleoside RT inhibitors with HIV-1 reverse transcriptase
    Sun, GY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2611 - U2611
  • [35] QSAR study by the RASMS method of DABO derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors
    Tong, J. -B.
    Bai, M.
    Zhao, X.
    JOURNAL OF STRUCTURAL CHEMISTRY, 2017, 58 (07) : 1418 - 1426
  • [36] Recent progress in HIV-1 inhibitors targeting the entrance channel of HIV-1 non-nucleoside reverse transcriptase inhibitor binding pocket
    Gu, Shuang-Xi
    Xiao, Ting
    Zhu, Yuan-Yuan
    Liu, Gen-Yan
    Chen, Fen-Er
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 174 : 277 - 291
  • [37] QSAR study by the RASMS method of DABO derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors
    J.-B. Tong
    M. Bai
    X. Zhao
    Journal of Structural Chemistry, 2017, 58 : 1418 - 1426
  • [38] Conformational preferences of non-nucleoside HIV-1 reverse transcriptase inhibitors
    Parreira, RLT
    Abrahao, O
    Galembeck, SE
    TETRAHEDRON, 2001, 57 (16) : 3243 - 3253
  • [39] Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Ruiz-Caro, J
    Basavapathruni, A
    Kim, JT
    Bailey, CM
    Wang, LG
    Anderson, KS
    Hamilton, AD
    Jorgensen, WL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 668 - 671
  • [40] Structural aspects of non-nucleoside HIV-1 reverse transcriptase inhibition
    Beyer, Anton
    Lawtrakul, Luckhana
    Pungpo, Pornpan
    Wolschann, Peter
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (02) : 87 - 100
12345